INSM Q1 2018 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$63M

Net Income

-$69M

EPS (Diluted)

$-0.89

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$73M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$773M

Total Liabilities

$338M

Stockholders' Equity

$435M

Cash & Equivalents

$687M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$63M	-$36M	-74.5%
Net Income	-$69M	-$37M	-83.2%